Skip to main content
Clinical Trials/NCT03285516
NCT03285516
Completed
Not Applicable

Improving Access to Evidence Based Care Among Rural Veterans Using a Transdiagnostic Treatment Approach

Southeast Louisiana Veterans Health Care System1 site in 1 country24 target enrollmentApril 16, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emotional Disorder
Sponsor
Southeast Louisiana Veterans Health Care System
Enrollment
24
Locations
1
Primary Endpoint
START Qualitative Treatment Questionnaire
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The primary aim of the current proposal is to test the acceptability and feasibility of a group-based transdiagnostic treatment, termed Safety Aid Reduction Treatment (START), delivered to rural Veterans. The anticipated results of the proposed study include: 1) START will be both acceptable and feasible to Veterans and mental health care providers, alike and 2) START will lead to meaningful reductions in symptoms of anxiety and depression.

Detailed Description

This is an intervention pilot project examining the acceptability, feasibility, and utility of a group-based transdiagnostic treatment delivered to rural Veterans. Approximately 5.2 million Veterans reside in rural communities across the United States, making it difficult for them to access quality medical and mental health (MH) care. The Department of Veterans Affairs (VA) established Community Based Outpatient Clinics (CBOCs) to improve access to healthcare for rural Veterans; however, these clinics often lack MH specialists including psychiatrists and psychologists, limiting the breadth of specialty services available. As such, MH care is often delivered by primary care providers or MH clinicians who (a) lack familiarity with evidence-based interventions and (b) lack the time needed to implement such intensive therapies. Group-based cognitive behavioral protocols that target a number of different diagnoses are likely to be more attractive in these settings and therefore more readily disseminated. Such protocols, often referred to as transdiagnostic treatments, are based on the theory that emotional disorders share common features and therefore respond to common therapeutic procedures. One such treatment, termed Safety Aid Reduction Treatment (START), has received increasing empirical support. This group-based transdiagnostic treatment is designed to address cognitive and behavioral strategies, otherwise known as safety aids, that are common across a number of psychiatric conditions (e.g., anxiety disorders, trauma- and stressor-related disorders, obsessive-compulsive and related disorders, and depressive disorders) and used to reduce anxiety. START has been found to effectively reduce psychopathology in community-based clinical samples and more recently among Veterans at the Southeast Louisiana Veterans Health Care System (SLVHCS). However, the utility of this treatment has yet to be examined in rural settings. Thus, the primary aim of the current proposal is to test the acceptability and feasibility of a group-based transdiagnostic treatment, termed START, delivered to rural Veterans at CBOCs. Because this is a pilot project, we will not emphasize symptom reduction, as we will likely be underpowered to detect treatment effects. Nevertheless, a secondary aim of the project is to examine the utility of START by gathering data on symptom change, which will be used as pilot data for a subsequent grant proposal. For this pilot project, Veterans (N = 24) will be recruited from two of the five Southeast Louisiana Veterans Health Care System (SLVHCS) CBOCs. The anticipated results of the proposed study include: 1) START will be both acceptable and feasible to Veterans and mental health care providers, alike and 2) START will lead to meaningful reductions in symptoms of anxiety and depression. Findings from the current study will help to advance our understanding of the amelioration of anxiety and depressive disorders among Veterans.

Registry
clinicaltrials.gov
Start Date
April 16, 2018
End Date
April 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

C Laurel Franklin, PhD

Clinical Psychologist

Southeast Louisiana Veterans Health Care System

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • Veterans must be diagnosed with an emotional disorder (e.g., anxiety disorder, obsessive-compulsive and related disorder, trauma-and stressor-related disorder, depressive disorder).
  • And be primarily served at a CBOC location.

Exclusion Criteria

  • \< 18 years of age
  • Currently dependent upon substances and in need of detoxification
  • Evidence of active psychosis
  • Acutely suicidal or homicidal
  • Uncontrolled bipolar disorder (e.g., not stable on medications)

Outcomes

Primary Outcomes

START Qualitative Treatment Questionnaire

Time Frame: 8 weeks

The START Qualitative Treatment Questionnaire is a brief, structured short-answer qualitative questionnaire that was developed by the research team to assess Veterans experience with the START protocol.

Secondary Outcomes

  • Overall Anxiety Severity and Impairment Scale (OASIS)(Baseline and 8 weeks and 12 weeks)
  • Work and Social Adjustment Scale (WSAS)(Baseline and 8 weeks and 12 weeks)
  • Overall Depression Severity and Impairment Scale (ODSIS)(Baseline and 8 weeks and 12 weeks)
  • Safety Behavior Assessment Form (SBAF)(Baseline and 8 weeks and 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials